Literature DB >> 19299709

Identification and characterization of a human CD5+ pre-naive B cell population.

Jisoo Lee1, Stefan Kuchen, Randy Fischer, Sooghee Chang, Peter E Lipsky.   

Abstract

We have identified a distinct pre-naive B cell population circulating in human peripheral blood that exhibits an intermediate phenotype between transitional and naive B cells. Like human transitional B cells, these cells express CD5 but have intermediate densities of CD38, CD10, CD9, and the ABCB1 transporter compared with transitional and naive B cells. These pre-naive B cells account for a majority of circulating human CD5(+) B cells. Importantly, CD5(+) pre-naive B cells could be induced to differentiate into cells with a naive phenotype in vitro. CD5(+) pre-naive B cells show only partial responses to BCR stimulation and CD40 ligation and undergo more spontaneous apoptosis and cell death than do naive B cells, whereas BAFF/BLyS (B cell-activating factor belonging to the TNF family) did not enhance their survival compared with naive B cells. In contrast, CD5(+) pre-naive B cells carry out certain functions comparable to naive B cells, including the capacity to differentiate into plasma cells and the ability to function as APCs. Notably, an increased proportion of CD5(+) pre-naive B cells were found in peripheral blood of patients with systemic lupus erythematosus. These results have identified a unique intermediate in human naive B cell development within the peripheral blood and derangements of its homeostasis in patients with systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299709     DOI: 10.4049/jimmunol.0803391

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

Review 1.  Microparticles as autoadjuvants in the pathogenesis of SLE.

Authors:  David S Pisetsky; Peter E Lipsky
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

2.  Reference values for B cell subpopulations from infancy to adulthood.

Authors:  H Morbach; E M Eichhorn; J G Liese; H J Girschick
Journal:  Clin Exp Immunol       Date:  2010-09-20       Impact factor: 4.330

Review 3.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

4.  A conserved enhancer element differentially regulates developmental expression of CD5 in B and T cells.

Authors:  Robert Berland; Steven Fiering; Henry H Wortis
Journal:  J Immunol       Date:  2010-11-12       Impact factor: 5.422

5.  Prenatal TCDD in mice increases adult autoimmunity.

Authors:  Steven D Holladay; Amjad Mustafa; Robert M Gogal
Journal:  Reprod Toxicol       Date:  2010-08-20       Impact factor: 3.143

Review 6.  The role of B-1 cells in inflammation.

Authors:  Monowar Aziz; Nichol E Holodick; Thomas L Rothstein; Ping Wang
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

7.  Hiding in plain sight: time to unlock autoimmune clues in human CD5+ B cells by using nextgen technology.

Authors:  Rizwan Ahmed; Zahra Omidian; Thomas Donner; Abdel Rahiam A Hamad
Journal:  Discov Med       Date:  2018-09       Impact factor: 2.970

8.  Transitional B cell subsets in human bone marrow.

Authors:  S Agrawal; S A B C Smith; S G Tangye; W A Sewell
Journal:  Clin Exp Immunol       Date:  2013-10       Impact factor: 4.330

Review 9.  Humoral immunity in humanized mice: a work in progress.

Authors:  Edward Seung; Andrew M Tager
Journal:  J Infect Dis       Date:  2013-11       Impact factor: 5.226

10.  Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells.

Authors:  Anouk Caraux; Bernard Klein; Bruno Paiva; Caroline Bret; Alexander Schmitz; Gwenny M Fuhler; Nico A Bos; Hans E Johnsen; Alberto Orfao; Martin Perez-Andres
Journal:  Haematologica       Date:  2010-01-15       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.